Agilent Technologies, Inc. (NYSE:A) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Agilent Technologies, Inc. (NYSE:A) have been assigned a consensus rating of “Moderate Buy” from the fifteen brokerages that are currently covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $149.6154.

A number of brokerages have issued reports on A. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. TD Cowen lifted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $170.00 in a research note on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. Finally, JPMorgan Chase & Co. boosted their price target on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th.

Agilent Technologies Stock Up 0.6%

Shares of NYSE:A opened at $142.01 on Friday. The stock has a fifty day simple moving average of $127.58 and a two-hundred day simple moving average of $117.83. The stock has a market capitalization of $40.26 billion, a price-to-earnings ratio of 33.34, a PEG ratio of 4.61 and a beta of 1.26. Agilent Technologies has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts anticipate that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Ethic Inc. raised its stake in shares of Agilent Technologies by 0.7% in the third quarter. Ethic Inc. now owns 19,291 shares of the medical research company’s stock worth $2,476,000 after purchasing an additional 128 shares during the last quarter. Live Oak Private Wealth LLC raised its stake in shares of Agilent Technologies by 5.0% in the third quarter. Live Oak Private Wealth LLC now owns 53,654 shares of the medical research company’s stock worth $6,886,000 after purchasing an additional 2,579 shares during the last quarter. Perigon Wealth Management LLC raised its stake in shares of Agilent Technologies by 27.3% in the third quarter. Perigon Wealth Management LLC now owns 3,821 shares of the medical research company’s stock worth $490,000 after purchasing an additional 819 shares during the last quarter. Apollon Wealth Management LLC raised its stake in shares of Agilent Technologies by 42.0% in the third quarter. Apollon Wealth Management LLC now owns 6,330 shares of the medical research company’s stock worth $813,000 after purchasing an additional 1,872 shares during the last quarter. Finally, CWM LLC raised its stake in shares of Agilent Technologies by 21.2% in the third quarter. CWM LLC now owns 70,390 shares of the medical research company’s stock worth $9,035,000 after purchasing an additional 12,294 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.